EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials

EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials

Jing-Xun Wu,1,* Qi He,1,* Feng Ye,1,* Qing-Xia Zhou,2 Hao-Jun Chen,3 Long Sun,3 Hua Wu3 1Department of Medical Oncology, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, China; 2Department of Medical Oncology, Wuzhong People’s Hospital, Wuzhong, China; 3...

Full description

Bibliographic Details
Main Authors: Wu JX, He Q, Ye F, Zhou QX, Chen HJ, Sun L, Wu H
Format: Article
Language:English
Published: Dove Medical Press 2018-10-01
Series:OncoTargets and Therapy
Subjects:
adjuvant treatment
epidermal growth factor receptor tyrosine kinase inhibitors; non-small cell lung cancer
Online Access:https://www.dovepress.com/egfr-tki-based-vs-non-egfr-tki-based-adjuvant-therapy-in-resected-non--peer-reviewed-article-OTT

Internet

https://www.dovepress.com/egfr-tki-based-vs-non-egfr-tki-based-adjuvant-therapy-in-resected-non--peer-reviewed-article-OTT

Similar Items